Print    Email

Related Information

New Test Helps Diagnose Intellectual Disability in Children

Scan tracks entire genome from a blood sample

FRIDAY, Jan. 17, 2014 (HealthDay News) -- A new test to help diagnose developmental delays and intellectual disability in children based on genetic abnormalities has been approved by the U.S. Food and Drug Administration.

The Affymetrix CytoScan DX Assay scans the entire genetic code from a blood sample and detects chromosomal variations that can lead to developmental and learning problems in children, the agency said Friday in a news release.

Intellectual disability affects as many as 3 percent of children in the United States, the agency said.

Analysis of 960 blood specimens found the new test was better at detecting chromosomal abnormalities that could lead to intellectual disability than other standard tests, the FDA said.

The new test is produced by Affymetrix Inc., based in Santa Clara, Calif.

More information

Medline Plus has more about intellectual disability.


Copyright © 2014 HealthDay. All rights reserved.

About Us

Contact Us

Careers

Education

Events

Finger Lakes College of Nursing

Geneva General Hospital Virtual Tour

Links

Listen to a Podcast

Marion S. Whelan School of Practical Nursing

Maps & Directions

Multimedia Library

News

Telephone Directory

Thrive Magazine

Community Service Plan

Report to the Community

      

Finger Lakes Health196 North Street, Geneva, NY 14456     315-787-4000